"Mount Sinai Researchers to Share Theranos Study Data"
After publishing a study evaluating Theranos' medical tests, the researchers are intending to collaborate with the company. “In the coming weeks, we are going to release the full dataset that was the basis of the study. In addition, the software code and statistical code that generated all the figures and results will be put in the public domain,” said co-author of the paper Joel Dudley, PhD, an assistant professor of genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai, in response to Theranos’ call for access to the study data. “That’s how good science is done.” Learn more.CNBC
The Tisch Cancer Institute Emphasizes Critical Role of BRCA Testing For All Genders
Oct 14, 2024 View All Press ReleasesNew Mount Sinai Research Brings Hope for Small Cell Lung Cancer Patients
Sep 30, 2024 View All Press ReleasesMount Sinai Researchers Publish Critical Examination of New Brain Tumor Drug
Sep 23, 2024 View All Press ReleasesNew AI Tool by Mount Sinai Researchers Could Reshape Prostate Cancer Care
Sep 23, 2024 View All Press ReleasesNew Insights Into Intellectual Disability Genetics Emerge at Mount Sinai
Sep 23, 2024 View All Press Releases